Effect of Institutional Experience on Outcomes of Alcohol
Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

J 2018

Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

VESELKA, Josef, Lothar FABER, Morten Kvistholm JENSEN, Robert COOPER, Jaroslav JANUSKA et. al.

Základní údaje

Originální název

Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Autoři

VESELKA, Josef (203 Česká republika, garant), Lothar FABER (276 Německo), Morten Kvistholm JENSEN (208 Dánsko), Robert COOPER (826 Velká Británie a Severní Irsko), Jaroslav JANUSKA (203 Česká republika), Jan KREJČÍ (203 Česká republika, domácí), Thomas BARTEL (784 Spojené arabské emiráty), Maciej DABROWSKI (616 Polsko), Peter Riis HANSEN (208 Dánsko), Vibeke Marie ALMAAS (578 Norsko), Hubert SEGGEWISS (276 Německo), Dieter HORSTKOTTE (276 Německo), Radka ADLOVA (203 Česká republika), Henning BUNDGAARD (208 Dánsko), Jurrien ten BERG (528 Nizozemské království) a Max LIEBREGTS (528 Nizozemské království)

Vydání

Canadian Journal of Cardiology, New York, Elsevier Science Ltd. 2018, 0828-282X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 5.592

Kód RIV

RIV/00216224:14110/18:00105231

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1016/j.cjca.2017.10.020

UT WoS

000418674300007

Klíčová slova anglicky

hypertrophic cardiomyopathy

Štítky

14110115, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 9. 2. 2019 22:30, Soňa Böhmová

Anotace

V originále

Background: The current American College of Cardiology Foundation/American Heart Association guidelines on hypertrophic cardiomyopathy state that institutional experience is a key determinant of successful outcomes and lower complication rates of alcohol septal ablation (ASA). The aim of this study was to evaluate the safety and efficacy of ASA according to institutional experience with the procedure. Methods: We retrospectively evaluated 1310 patients with symptomatic obstructive hypertrophic cardiomyopathy who underwent ASA and were divided into 2 groups. The first-50 group consisted of the first consecutive 50 patients treated at each centre, and the over-50 group consisted of patients treated thereafter (patients 51 and above). Results: In the 30-day follow-up, there was a significant difference in the occurrence of major cardiovascular adverse events (21% in the first-50 group vs 12% in the over-50 group; P < 0.01), which was driven by the occurrence of cardiovascular deaths (2.1% vs 0.4%; P = 0.01) and implanted pacemakers (15% vs 9%; P < 0.01). In the long-term follow-up (5.5 +/- 4.1 years), the first-50 group was associated with a significantly higher occurrence of major adverse events (P < 0.01) and higher cardiovascular mortality (P < 0.01). Also, patients in the first-50 group were more likely to self-report dyspnea of New York Heart Association class III/IV (16% vs 10%), to have a left ventricular outflow gradient > 30 mm Hg (16% vs 10%) at the last clinical check-up (P < 0.01 for both), and a probability of repeated septal reduction therapy (P = 0.03). Conclusions: An institutional experience of > 50 ASA procedures was associated with a lower occurrence of ASA complications, better cardiovascular survival, better hemodynamic and clinical effect, and less need for repeated septal reduction therapy.

Citovat

VESELKA, Josef, Lothar FABER, Morten Kvistholm JENSEN, Robert COOPER, Jaroslav JANUSKA, Jan KREJČÍ, Thomas BARTEL, Maciej DABROWSKI, Peter Riis HANSEN, Vibeke Marie ALMAAS, Hubert SEGGEWISS, Dieter HORSTKOTTE, Radka ADLOVA, Henning BUNDGAARD, Jurrien ten BERG a Max LIEBREGTS. Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. Canadian Journal of Cardiology. New York: Elsevier Science Ltd., 2018, roč. 34, č. 1, s. 16-22. ISSN 0828-282X. Dostupné z: https://dx.doi.org/10.1016/j.cjca.2017.10.020.

@article{1483018,
   author = {Veselka, Josef and Faber, Lothar and Jensen, Morten Kvistholm and Cooper, Robert and Januska, Jaroslav and Krejčí, Jan and Bartel, Thomas and Dabrowski, Maciej and Hansen, Peter Riis and Almaas, Vibeke Marie and Seggewiss, Hubert and Horstkotte, Dieter and Adlova, Radka and Bundgaard, Henning and Berg, Jurrien ten and Liebregts, Max},
   article_location = {New York},
   article_number = {1},
   doi = {http://dx.doi.org/10.1016/j.cjca.2017.10.020},
   keywords = {hypertrophic cardiomyopathy},
   language = {eng},
   issn = {0828-282X},
   journal = {Canadian Journal of Cardiology},
   title = {Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy},
   volume = {34},
   year = {2018}
}

TY  - JOUR
ID  - 1483018
AU  - Veselka, Josef - Faber, Lothar - Jensen, Morten Kvistholm - Cooper, Robert - Januska, Jaroslav - Krejčí, Jan - Bartel, Thomas - Dabrowski, Maciej - Hansen, Peter Riis - Almaas, Vibeke Marie - Seggewiss, Hubert - Horstkotte, Dieter - Adlova, Radka - Bundgaard, Henning - Berg, Jurrien ten - Liebregts, Max
PY  - 2018
TI  - Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
JF  - Canadian Journal of Cardiology
VL  - 34
IS  - 1
SP  - 16-22
EP  - 16-22
PB  - Elsevier Science Ltd.
SN  - 0828282X
KW  - hypertrophic cardiomyopathy
N2  - Background: The current American College of Cardiology Foundation/American Heart Association guidelines on hypertrophic cardiomyopathy state that institutional experience is a key determinant of successful outcomes and lower complication rates of alcohol septal ablation (ASA). The aim of this study was to evaluate the safety and efficacy of ASA according to institutional experience with the procedure. Methods: We retrospectively evaluated 1310 patients with symptomatic obstructive hypertrophic cardiomyopathy who underwent ASA and were divided into 2 groups. The first-50 group consisted of the first consecutive 50 patients treated at each centre, and the over-50 group consisted of patients treated thereafter (patients 51 and above). Results: In the 30-day follow-up, there was a significant difference in the occurrence of major cardiovascular adverse events (21% in the first-50 group vs 12% in the over-50 group; P < 0.01), which was driven by the occurrence of cardiovascular deaths (2.1% vs 0.4%; P = 0.01) and implanted pacemakers (15% vs 9%; P < 0.01). In the long-term follow-up (5.5 +/- 4.1 years), the first-50 group was associated with a significantly higher occurrence of major adverse events (P < 0.01) and higher cardiovascular mortality (P < 0.01). Also, patients in the first-50 group were more likely to self-report dyspnea of New York Heart Association class III/IV (16% vs 10%), to have a left ventricular outflow gradient > 30 mm Hg (16% vs 10%) at the last clinical check-up (P < 0.01 for both), and a probability of repeated septal reduction therapy (P = 0.03). Conclusions: An institutional experience of > 50 ASA procedures was associated with a lower occurrence of ASA complications, better cardiovascular survival, better hemodynamic and clinical effect, and less need for repeated septal reduction therapy.
ER  -

VESELKA, Josef, Lothar FABER, Morten Kvistholm JENSEN, Robert COOPER, Jaroslav JANUSKA, Jan KREJČÍ, Thomas BARTEL, Maciej DABROWSKI, Peter Riis HANSEN, Vibeke Marie ALMAAS, Hubert SEGGEWISS, Dieter HORSTKOTTE, Radka ADLOVA, Henning BUNDGAARD, Jurrien ten BERG a Max LIEBREGTS. Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. \textit{Canadian Journal of Cardiology}. New York: Elsevier Science Ltd., 2018, roč.~34, č.~1, s.~16-22. ISSN~0828-282X. Dostupné z: https://dx.doi.org/10.1016/j.cjca.2017.10.020.

Podrobný výpis o publikaci